523results about "Esterified saccharide compounds" patented technology

The disclosure provides compounds useful for treating alpha-1 antitrypsin deficiency (AATD), according to formula (I):tautomers thereof, pharmaceutically acceptable salts of the compounds, pharmaceutically acceptable salts of the tautomers, deuterated derivatives of the compounds, deuterated derivatives of the tautomers, and deuterated derivatives of the salts, solid forms of those compounds and processes for making those compounds.

The present disclosure includes ionizable lipids suitable for lipid nanoparticle compositions and pharmaceutical formulations thereof. The lipids have general formula (I).

The invention discloses a genetically engineered bacterium for producing glucuronic acid as well as a construction method and application of the genetically engineered bacterium, and belongs to the technical field of genetic engineering. According to the genetically engineered bacterium for producing glucuronic acid, an inositol oxidase gene MMIOX is integrated on a site of a uronic acid isomerase gene uxaC. According to the invention, an inositol oxidase gene MMIOX is integrated on a genome of a genetically engineered bacterium for producing glucuronic acid, and a uronic acid isomerase gene uxaC is knocked out at the same time, so that the genetically engineered bacterium can efficiently catalyze inositol reaction to generate glucuronic acid through the integrated inositol oxidase gene MMIOX; the glucuronic acid isomerase gene uxaC is knocked out, so that isomerization reaction of glucuronic acid can be avoided, and the yield of glucuronic acid is further increased.

The invention discloses a toughening agent, a toughened epoxy resin adhesive and a preparation method and application thereof. The toughening agent is obtained by carrying out esterification reaction on components including a phenolic compound containing a polyphenol skeleton and an anhydride compound containing a long-chain alkyl structure. The raw materials used by the toughening agent are bio-based molecules and have excellent renewability, the toughening agent is high in toughening efficiency, the impact strength of the epoxy resin adhesive can be effectively improved under the condition of low addition amount, and meanwhile, the bonding strength and the hydrothermal durability of the epoxy resin adhesive can be improved.

The invention discloses a ferroptosis inhibitor and application of the ferroptosis inhibitor in radiation pneumonitis drugs, and relates to the technical field of biological medicines. The specific preparation method comprises the following steps: adding the ferroptosis inhibitor and the auxiliary agent into the solvent, and dissolving to obtain the ferroptosis inhibitor composition; wherein the ferroptosis inhibitor is isoorientin; the auxiliary agent is a glucosamine derivative; the solvent is a serum-free DMEM culture medium. The ferroptosis inhibitor composition prepared by the method provided by the invention can effectively reduce the rise of active oxygen, ferrous ions and malondialdehyde levels of human pulmonary epithelial cells BEAS-2b and mouse pulmonary epithelial cells MLE-12 caused by irradiation, restore cell mitochondrial membrane potential enrichment and inhibit the expression of various inflammatory factors in irradiated cells; therefore, the process of radiation pneumonitis is remarkably improved, and a new medication strategy is provided for research on radiation pneumonitis drugs.

The present disclosure provides linker compounds of Formula (I) or (II):pharmaceutically acceptable salts thereof, and related scaffolds and conjugates. The present disclosure also relates to uses of the linker compounds, scaffolds, and conjugates, e.g., in delivering nucleic acid and / or treating or preventing diseases.

The invention belongs to the technical field of pesticides, and particularly relates to azobenzene calix [4] arene derivatives as well as a preparation method and application thereof. The invention discloses a novel azobenzene calix [4] arene derivative prepared by directional modification through an azo reduction reaction based on a calix [4] arene skeleton. The azobenzene calix [4] arene derivative has the characteristics of green environmental protection, accurate and controllable structure and efficient synthesis. After the derivative and a pesticide form a host-guest compound, the activity of the pesticide can be remarkably improved, the bioavailability of the pesticide at an action site is increased, the problem of low efficiency of the traditional pesticide is effectively solved, and the development of target drug resistance is delayed. The technology breaks through the technical bottleneck of nano-carrier environmental toxicity, provides a new thought for developing a multi-target and low-environmental-risk pesticide synergist, and has important significance for realizing pesticide decrement, synergism and resistance treatment.

The invention discloses a sialic acid molecular imprinting extraction method, and belongs to the technical field of separation and purification. The invention discloses a sialic acid molecular imprinting extraction method which comprises the following steps: dissolving a sialic acid standard substance and a functional monomer in a binary pore-foaming agent-ionic liquid, adding a cross-linking agent and an initiator, polymerizing under ultraviolet light to prepare a high-molecular polymer, and washing off the sialic acid standard substance to prepare a molecular imprinting polymer; specifically adsorbing sialic acid in the fermentation liquor by using the molecularly imprinted polymer; performing graded elution on sialic acid by using a methanol-water mixed solution and a methanol-acetic acid mixed solution; and performing rotary evaporation concentration, anti-solvent crystallization, separation and drying on the bird's nest acid eluent. Tests show that the sialic acid purity is greater than or equal to 99%, and can meet the requirements of the sialic acid in the fields of food, health care, medicine, cosmetics and the like. According to the method, sialic acid can be efficiently separated and extracted from sialic acid fermentation liquor, the product yield is increased, the extraction procedures are reduced, and the production cost and the discharge amount of three wastes are reduced.

The invention relates to the technical field of radiopharmaceutical chemistry and clinical nuclear medicine, in particular to preparation and application of isonitrile mannose cuprous complex salt derivatives. The structure of the isonitrile mannose cuprous complex salt derivative is shown in (I), the isonitrile mannose cuprous complex salt derivative is good in stability, a marking method is simple when a freeze-drying medicine box prepared from the isonitrile mannose cuprous complex salt derivative is used for preparing < 99m > Tc tumor marking radiopharmaceuticals, the marking rate of a final product is larger than 90%, the tumor affinity performance is good, and clinical application and popularization are convenient. # imgabs0 #

The present invention relates to the technical field of traditional Chinese medicine extraction and detection, and particularly relates to an extraction method for tannin fractions in fresh Terminalia chebula, an extraction and purification method for tannin compounds, and a detection method. The extraction method for tannin fractions in fresh Terminalia chebula provided by the present invention uses fresh Terminalia chebula fruits as raw materials, and successively performs stone removal, water-added juicing, and ultrasonic extraction, which can not only avoid the degradation of tannic acid, but also obtain an ideal extraction rate, and has a simple process, low energy consumption, and short time consumption. The present invention also provides an extraction and purification method for tannin compounds. Through macroporous adsorption resin elution, alcohol precipitation, octadecylsilyl reverse-phase packing column elution, and preparative chromatography separation, high-purity chebulic acid, gallic acid, 4-galloylshikimic acid, and 5-galloylshikimic acid can be obtained. The detection method provided by the present invention can detect more than ten tannin components, has high efficiency, and helps to provide data support for the in-depth study of tannin components in Terminalia chebula.

To provide a compound and the use thereof for the treatment for regeneration of connective tissue following the degeneration process of articular cartilage due to osteoarthritis, in the case of humans, the degeneration process of articular cartilage caused by excessive stress, for the treatment of skin aging, and for the prevention of skin cancer.SOLUTION: For example, an amino acid derivative of glucosamine having the following structure is provided.SELECTED DRAWING: None

The invention discloses a method for synthesizing a benzodithiepinone derivative through metal-free catalysis, and belongs to the field of organic synthesis. According to the method, benzo disulfonylphenol ketone and alkyne are taken as raw materials, a dual-catalysis system composed of triethylene diamine and bis (diphenylphosphine) methane is adopted, a heating reaction is performed in a 1, 4-dioxane solvent, and the target seven-membered sulfur heterocycle (benzo [e] [1, 4] dithiepin-5-ketone compound) is obtained through separation and purification. According to the method, the problem of regioselective sulfuration of alkyne is effectively solved through a synergistic catalysis mechanism of organic amine and organic phosphine, and high-precision cyclization reaction of benzobissulfonylphenol ketone and alkyne is realized. The process is mild in reaction condition, free of inert gas protection, simple and convenient to operate and good in functional group tolerance, the atom economy can reach 100%, and an efficient and practical synthesis way is provided for construction of the benzo [e] [1, 4] dithiepin-5-ketone compound with a novel structure.

The present invention discloses a method for simultaneously separating and purifying Tellimagrandin I and II from oil-tea camellia shell. The oil-tea camellia shell raw material is crushed and extracted with an organic solvent. After the first extract is filtered and concentrated, the concentrated solution is alkalized, heated, allowed to stand, and filtered to obtain a second extract. After the second extract is acidified, it is extracted with an extractant. The extract is concentrated to obtain a mixture containing low contents of Tellimagrandin I and II. The mixture with low contents of Tellimagrandin I and II is decolorized and eluted with solvents in different proportions to obtain compounds with high contents of Tellimagrandin I and II. The Tellimagrandin I and II obtained by the present invention have a purity greater than 98% and a yield greater than 0.5%. This method is simple, efficient and suitable for large-scale production.

The present invention relates to a method for separating acidic sophorolipids, or lactone sophorolipids, in particular acidic sophorolipids rich in acetylated acid sophorolipids, from products containing lactone / acid sophorolipids, and to the acidic sophorolipids, in particular acidic sophorolipids rich in acetylated acid sophorolipids, obtained by said method.

Disclosed are 1,2,4,5-tetraoxane compounds and derivatives thereof having anticancer properties. Disclosed are pharmaceutical compositions and pharmaceutical formulations in unit dosage form suitable for delivering the compounds to a subject in need thereof. In addition to the compounds, the pharmaceutical compositions or formulations can include one or more active agents, such as one or more additional anticancer agents. Also disclosed are methods of treating, mitigating, or treating or ameliorating one or more symptoms associated with cancer in a subject. The methods include (i) administering to a subject in need thereof an effective amount of a compound. The compound can be administered by oral administration, parenteral administration, inhalation, mucosal administration, or a combination thereof. The compound can selectively kill cancer cells and / or cancer stem cells, but not non-cancer cells, by inducing ferroptosis in the cancer cells and / or cancer stem cells.

The invention discloses a method for preparing fructose 1, 6-diphosphate, which comprises the following steps of: inoculating saccharomycetes into a culture medium, reacting by taking glucose as a substrate, and carrying out solid-liquid separation, clear liquid collection, ultrafiltration, permeate collection, nanofiltration, trapped fluid collection and drying on the obtained reaction liquid to obtain the fructose 1, 6-diphosphate, wherein the culture medium contains aldehyde compounds. When the method is used for producing the FDP, the single-batch catalytic yield is increased from 60g / L to 85g / L.

The present invention relates to compounds effective in the treatment of hepatotoxicity and fatty liver diseases and uses thereof.

Provided is an N-acetyllactosamine-containing composition production method that achieves a higher rate of conversion from N-acetylglucosamine to N-acetyllactosamine as compared to conventional methods and that is simple but has no effect on the flavor. The production method provided is a method in which N-acetyllactosamine is produced using an enzyme reaction through the action of β-galactosidase on lactose and N-acetylglucosamine, wherein the lactose concentration before the action of β-galactosidase is 1.1 times or more the N-acetylglucosamine concentration in amount-of-substance ratio. An N-acetyllactosamine-containing composition produced by the production method is also provided, wherein the amount-of-substance ratio of N-acetyllactosamine (LacNAc) to N-acetylglucosamine (GlcNAc) (LacNAc / GlcNAc) contained in the composition is 0.26 or more.

The present invention provides a retinoic acid derivative that has high stability and water solubility. The present invention relates to a carboxylic acid ester compound of trehalose or a derivative thereof and retinoic acid.

The invention relates to the technical field of medical adsorbents for blood perfusion, and discloses an application of a trans-cyclooctene group adsorbent based on a biological orthogonal reaction in preparation of a circulating tumor cell clearing preparation. The adsorbent adopts sephadex microspheres as a carrier, the surface of the carrier is modified with a trans-cyclooctene (TCO) group, a tetrazine (Tz) group is taken in by CTCs through modified mannose, the Tz group is expressed on the surface of a CTCs cell membrane in the form of glycoprotein through a Roseman-Warden pathway in cells, TCO and Tz are subjected to a biological orthogonal reaction specifically, and the adsorption capacity of the adsorbent is improved. The sephadex microsphere adsorbent can effectively enrich and remove CTCs in blood of the whole body of a patient through adsorption, and compared with a conventional single-antibody or multi-antibody capture technology, the sephadex microsphere adsorbent does not depend on antibody-antigen binding, and the capture efficiency of the CTCs can be remarkably improved through a biological orthogonal reaction.

The application discloses an intelligent response type nutrient polymerization slow-release fertilizer and a preparation method thereof, and belongs to the technical field of slow-release fertilizers. The intelligent response type nutrient polymerization slow-release fertilizer of the application solves the problem that the molecular chain length of the nutrient polymerization slow-release fertilizer cannot be controlled by adopting a brominated acetylated substance modified methylene urea technology, and solves the problem that the fertilizer and crop interaction ability is poor by connecting an acid-sensitive substance to a methylene urea fragment with a determined nutrient release period. Organic acid secreted by roots can respond to the nutrient polymerization slow-release fertilizer, so as to promote the release of nutrients, and the nutrient release rate and release amount are positively correlated with the amount of the organic acid secreted by the roots, and the fitting degree with the crop fertilizer requirement law is also higher. Therefore, the nutrient polymerization slow-release fertilizer which can respond to the root nutrient demand signal secretion will be more widely applied to different crops such as wheat, corn, peanut, vegetable and fruit trees, and the application area will be more extensive.

The invention belongs to the technical field of biology, and particularly relates to acetylated raffinose and application thereof. According to the invention, acetylation modification is carried out on raffinose by using an acetylation reagent to obtain acetylated raffinose, the acetylated raffinose can significantly improve the scavenging ability and total antioxidant ability of raffinose on DPPH free radicals, and the scavenging ability on hydroxyl free radicals and the reduction ability on iron ions are also improved to a certain extent. The acetylated raffinose provided by the invention has potential application value in development of functional foods and antioxidants.

The present application relates to a kind of efficient active separation and purification method and purposes of elaeagnus conferta polyphenol, comprising: elaeagnus conferta powder is extracted with ethanol solution, after ultrasonic extraction, centrifugal supernatant is obtained, repeat multiple times after being combined, concentrated by rotary evaporation, and obtain elaeagnus conferta polyphenol concentrated extract;Elaeagnus conferta polyphenol concentrated extract is centrifuged, and the supernatant is used as chromatography sample liquid;Chromatography sample liquid is added to Flash liquid chromatography by liquid sample loading mode, is separated by gradient elution mode to chromatographic column, and each elution component is collected in turn, and concentrated respectively;The concentrated solution of each elution component is added to chromatographic column again to carry out second gradient elution separation, and chromatographic column separation elution is repeated three times, and three kinds of purified elaeagnus conferta polyphenol components are obtained after freeze drying.The present application realizes the high-resolution fractionation elution of polyphenol monomer with high structural similarity by the synergistic regulation of mobile phase polarity gradient and elaeagnus conferta polyphenol molecular hydrophobic interaction.

The application discloses a glucuronolactone and a preparation method thereof, and belongs to the technical field of fine chemical product preparation. The method takes potassium phytate extracted from corn soaking liquid or rice bran acid soaking liquid as raw material, obtains inositol and potassium dihydrogen phosphate after hydrolysis, separates the hydrolysis liquid through chromatography, obtains potassium dihydrogen phosphate by concentrating and crystallizing the salt phase, and the material phase is inositol solution. Enzymatic conversion reaction is carried out by using fermentation to obtain enzyme liquid, glucuronic acid liquid is obtained, glucuronolactone is obtained by concentrating and esterifying, and then the glucuronolactone is obtained by concentrating, refining and crystallizing. In the method, the yield of potassium phytate to inositol is greater than 95%, the molar conversion rate of inositol enzymatic conversion to glucuronic acid is greater than 95%, and the total yield is greater than 89%, which is much higher than the traditional yield, and the content of the obtained glucuronolactone is greater than 99.2%. The glucuronolactone is prepared by enzymatic conversion of the intermediate inositol, the by-product is high-value potassium dihydrogen phosphate, the whole has good economic benefits, and industrial production can be realized.

The current invention concerns methods for the synthesis of 6-azido-6-deoxy-2-N-acetyl-monosaccharide-nucleoside diphosphate, in particular 6-azido-6-deoxy-2-N-acetyl-D-galactosamine-nucleoside diphosphate or 6-azido-6-deoxy-2-N-acetyl-D-glucosamine-nucleoside diphosphate. The synthesis method according to the invention is characterized by being highly efficient and high yielding. Also part of the present invention are key intermediates of this process.

The present application relates to a disaccharide linker, a disaccharide-small molecule drug conjugate and a sugar chain fixed-point antibody-drug conjugate, a preparation method and the use thereof. The structure of the disaccharide linker is as shown in the following formula I. The present invention provides a new-type fixed- point and quantitative antibody-drug conjugate form, and the stability and cytotoxicity of the antibody-drug conjugate are improved.

Methods of preparing steviol glycosides are described. The methods include utilizing enzyme preparations and recombinant microorganisms for converting various starting compositions to target steviol glycosides. The steviol glycosides are useful as non- caloric sweetener, flavor enhancer, sweetness enhancer, flavor stabilizer, flavoring with modifying properties (FMP), foaming suppressor and solubility enhancing agent in consumable products such as any food, beverages, pharmaceutical compositions, tobacco products, nutraceutical compositions, and oral hygiene compositions.

The invention discloses a chondroitin sulfate oligosaccharide derivative and a preparation method and application thereof.The chondroitin sulfate oligosaccharide derivative is shown in the formula (I), the definition of substituent groups in the formula is shown in the specification, and the derivative comprises di-, tetra-and hexasaccharide derivatives of chondroitin sulfate B and T, has endogenous anticoagulation and anti-inflammatory activity, and can be used for preparing the chondroitin sulfate oligosaccharide derivative. The compound can be developed into anticoagulant and antithrombotic drugs.